Dear Colleague,

I am pleased to inform you that the 6th edition of the European Statistical Forum will be held in Vienna on Monday, 16th November

The sixth edition of the European Statistical Forum is dedicated to the application of statistical methodology in early drug development, focusing in particular on:

• Current state-of-the art dose finding trial designs like MCPMod
• Statistical techniques on the integration of biomarker as well as pharmacogenetic data into the early drug development process
• Implementation of efficient Proof of Principle and Proof of Concept trials
• Transfer of the preclinical knowledge into first in human trials
• New developments in and designs for PK and PK/PD trials
• Recent enhancements in statistical methodology by leaders in academia

Both case studies and methodological background will be covered. The conference aims at promoting the exchange of expertise, bringing together statisticians, pharmacometricians, physicians, regulators, academia and other experts interested in the field of early drug development.

An advanced-draft agenda is now available. The Scientific Board, Jens-Otto Andreas (Head EU Biostatistics at UCB Biosciences GmbH), Lisa Comarella (Director Biostatistics and Senior Project Manager at CROS NT Group), Frank Fleischer (Global BCA at Boehringer Ingelheim Pharma GmbH & Co. KG) and Giacomo Mordenti (Senior Director Compound Development & Branding-Head Biostatistics at Grünenthal) will moderate the conference and speeches of expert Speakers, who will cover the following subjects:

A Statistical Framework for Decision Making in Early Clinical Development
James Matcham
– Head, Early Clinical Development Biometrics, AstraZeneca UK

Efficient design of an academic dose finding trial with intraindividual comparison to placebo
Arne Ring
– Professor of Statistics and Principal Statistician, University of Leicester

MCP-Mod in longitudinal phase II trials – practical experiences in the pharmaceutical industry
Lieven Kennes
– Department of Biometrics, Grünenthal GmbH

Incorporating a search for predictive biomarkers into clinical trials
Foteini Strimenopoulou
– Principal Exploratory Statistician, UCB UK
Ros Walley – Director Exploratory Statistics, UCB UK

Statistics in Early Clinical Development – The Way Ahead of Us
Harry Mager
– Senior Director / Expert Statistician Pharmacometrics – Early Drug Development, Bayer Pharma AG, Berlin
Richardus Vonk – Senior Director, Head of Research and Clinical Sciences Statistics, Bayer Pharma AG

Maximize your ability to make predictions using Bayesian optimal designs
Bruno Boulanger
– CSO, Arlenda

MCPMod for the Adaptive Design and Analysis of Dose-Finding studies under Model-uncertainty
Tobias Mielke
– Statistical Consultant, ICON PLC

The final agenda will be available soon
Click here to read abstracts

Early Bird discount  for enrolment by 16th October

Free pre-Conference Dinner for registration forms received before June 26th.

For further information or if you would like to reserve a place, please visit the European Statistical Forum website and do not hesitate to contact me.

Looking forward to meeting you in Vienna,

Best Regards,

Chiara Garofalo
Project and Scientific Manager

European Statistical Forum – EasyB S.r.l.

-- Descargar Applications of statistical methodology in early drug development - Advanced-draft agenda como PDF --